赛生药业(06600.HK)稳定价格期间结束
赛生药业(06600.HK)公布,稳定价格操作人中国国际金融香港证券或代其行事的任何人士於稳定价格期间,超额分配国际发售合共1,739.75万股股份,占超额配售权获行使前全球发售初步可供认购发售股份总数的15%。
而稳定价格操作人根据借股协议向GL Trade Investment L.P.借入合共1,739.75万股股份,以补足国际发售的超额分配。并於稳定价格期间内以介乎每股股14.28-18.8元的价格接连在市场购入合1,739.75万股股份,占超额配售权获行使前全球发售初步可供认购发售股份总数的15%。
联席代表未於稳定价格期间内行使超额配售权,超额配售权已於2021年3月26日失效,概无股份已经或将会根据超额配售权发行。(el/k) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.